Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer.

Aging - 19 Dec 2020

Yan Yilin, Huang Zhengnan, Cai Jinming, Tang Pengfei, Zhang Fang, Tan Mingyue, Shen Bing

Abstract excerpt

Few studies have investigated the potential of tumor immune microenvironment genes as indicators of urinary bladder cancer. Here, we sought to establish an immune-related gene signature for determining prognosis and treatment options. We developed a ten-gene tumor immune microenvironment signature and evaluated its prognostic capacity on internal and external cohorts. Multivariate Cox regression and nomogram...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Carcinoma, Transitional Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Checkpoint Inhibitors

Share to Lymphocytes, Tumor-Infiltrating

Share to Programmed Cell Death 1 Receptor

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Retinoblastoma Binding Proteins

Share to Tumor-Associated Macrophages

Source

Open in PubMed Open full text

Identifiers

PMID: 33408272
DOI: 10.18632/aging.202327
PMCID: PMC7880321

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer.PMID 33408272Read ↗

Analysis of tumor microenvironment characteristics in bladder cancer: implications for immune checkpoint inhibitor therapySemantic proximity Read ↗

Correlation between the immune microenvironment and bladder cancer based on a prognostic miRNA risk modelSemantic proximity Read ↗

New exploration of bladder cancer-related immune gene biomarkers in predicting the prognosis of urinary system tumorsSemantic proximity Read ↗

The Immunogenomic Landscape of and Immune Cell Infiltration in Bladder CancerSemantic proximity Read ↗

Metabolic‐associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancerSemantic proximity Read ↗

Identification of Microenvironment-Related Prognostic Genes in Bladder Cancer Based on Gene Expression ProfileSemantic proximity Read ↗

An Immune-Related Clinical-Gene-Risk-Score (CGRS) prognosis Model for Bladder CancerSemantic proximity Read ↗

Risk stratification based on immune signature and prediction of immune checkpoint inhibitor’s efficacy for bladder urothelial carcinomaSemantic proximity Read ↗

Metabolic-Associated Signature and Hub Genes Associated with Immune Microenvironment and Prognosis in Bladder CancerSemantic proximity Read ↗

Screening and Identifying Immune-Related Cells and Genes in the Tumor Microenvironment of Bladder Urothelial Carcinoma: Based on TCGA Database and BioinformaticsSemantic proximity Read ↗

Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC).Semantic proximity Read ↗

Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.